Protagonist Therapeutics Inc (PTGX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

7707 GATEWAY BLVD., SUITE 140 NEWARK, CA 94560-1160

Protagonist Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. Protagonist Therapeutics serves customers worldwide.

Data based on most recent fiscal year report
Market Cap176.947 Million Shares Outstanding20.48 Million Avg Volume175.581 Thousand
1-Yr BETA vs S&P TR0.733 Current Ratio3.55 Quick Ratio3.55
View SEC Filings from PTGX instead.
Q2 2019 All Institutions Hedge Funds 1
To trade PTGX now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 68 20 (2.07%)
Aggregate 13F shares on 06/30/2019: 19.293 Million 9.539 Million
Aggregate 13F shares on 03/31/2019: 17.134 Million 8.862 Million
Percent change: 12.60% 7.64%
Funds creating new positions: 15 3
Funds Adding to an existing position: 30 11
Funds closing out their position: 13 4
Funds reducing their position: 16 4
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PTGX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHANAFELT ARMEN

  • Director
  • 10% Owner
0 2019-10-01 0

GIRAUDO BRYAN CHIEF FINANCIAL OFFICER

  • Officer
26,000 2019-09-26 1

O'NEIL THOMAS P. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-09-12 0

WILLIAMS LEWIS T

  • Director
455,336 2019-09-01 1

NOONBERG SARAH B.

  • Director
0 2019-08-08 1

PATEL DINESH V PH D PRESIDENT AND CEO

  • Officer
  • Director
374,792 2019-08-06 4

LIU DAVID Y CHIEF SCIENTIFIC OFFICER

  • Officer
49,802 2019-08-06 3

SELICK HAROLD E

  • Director
0 2019-06-20 2

SAKS SAMUEL R

  • Director
0 2019-06-20 2

WADDILL WILLIAM D.

  • Director
0 2019-06-07 1

KHOSLA CHAITAN PHD

  • Director
0 2019-06-07 1

KALKOFEN DONALD A. CHIEF FINANCIAL OFFICER

  • Officer
0 2019-05-31 2

CANAAN X L.P.

CANAAN PARTNERS X LLC

  • 10% Owner
2,660,713 2019-05-28 0

SHAMES RICHARD S. CHIEF MEDICAL OFFICER

  • Officer
32,021 2019-02-28 2

GUPTA SUNEEL EVP CLINICAL OPERATIONS

  • Officer
17,500 2019-02-28 3

MURPHY NIALL VP, CONTROLLER, INTERIM PAO

  • Officer
0 2019-01-11 1

JOHNSON & JOHNSON

JOHNSON & JOHNSON INNOVATION - JJDC, INC.

  • 10% Owner
No longer subject to file 2018-07-19 0

LV MANAGEMENT GROUP, LLC

LILLY VENTURES FUND I LLC

TORRES S. EDWARD

HALL STEVEN EDWARD

  • 10% Owner
3,447,817 2018-04-23 0

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
No longer subject to file 2017-12-31 0

PAPANEK JULIE

  • Director
0 2017-05-25 0

HODDER WILLIAM A SR. VP - CORPORATE DEVELOPMENT

  • Officer
0 2016-10-11 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments